Wells Fargo & Company MN Sells 36,229 Shares of Mazor Robotics Ltd – (MZOR)
Wells Fargo & Company MN trimmed its position in shares of Mazor Robotics Ltd – (NASDAQ:MZOR) by 32.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 76,310 shares of the medical instruments supplier’s stock after selling 36,229 shares during the period. Wells Fargo & Company MN’s holdings in Mazor Robotics were worth $3,768,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently made changes to their positions in MZOR. Private Advisor Group LLC purchased a new stake in shares of Mazor Robotics during the second quarter worth $517,000. Columbia Partners L L C Investment Management acquired a new position in Mazor Robotics during the second quarter worth $1,847,000. Menta Capital LLC increased its position in Mazor Robotics by 85.3% during the second quarter. Menta Capital LLC now owns 50,737 shares of the medical instruments supplier’s stock worth $1,754,000 after buying an additional 23,357 shares during the last quarter. Biondo Investment Advisors LLC acquired a new position in Mazor Robotics during the second quarter worth $675,000. Finally, Quantbot Technologies LP acquired a new position in Mazor Robotics during the second quarter worth $135,000. Institutional investors and hedge funds own 26.37% of the company’s stock.
Several research firms have commented on MZOR. Ladenburg Thalmann Financial Services set a $67.00 target price on shares of Mazor Robotics and gave the stock a “buy” rating in a research report on Monday, October 30th. Needham & Company LLC reissued a “hold” rating on shares of Mazor Robotics in a research report on Tuesday, November 7th. Barclays reissued a “hold” rating and set a $34.00 target price on shares of Mazor Robotics in a research report on Wednesday, October 11th. Zacks Investment Research downgraded shares of Mazor Robotics from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 13th. Finally, TheStreet raised shares of Mazor Robotics from a “d” rating to a “c-” rating in a research report on Wednesday, November 8th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $43.17.
About Mazor Robotics
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.
Want to see what other hedge funds are holding MZOR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mazor Robotics Ltd – (NASDAQ:MZOR).
Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.